Godavari Drugs (BOM:530317) Other Net Income (Loss) : ₹0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Other Net Income (Loss)?

Godavari Drugs's Other Net Income (Loss) for the three months ended in Dec. 2023 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Godavari Drugs's quarterly Other Net Income (Loss) increased from Jun. 2023 (₹-0 Mil) to Sep. 2023 (₹0 Mil) but then stayed the same from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹0 Mil).

Godavari Drugs's annual Other Net Income (Loss) stayed the same from Mar. 2021 (₹0 Mil) to Mar. 2022 (₹0 Mil) but then declined from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹-0 Mil).

Godavari Drugs Other Net Income (Loss) Historical Data

The historical data trend for Godavari Drugs's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Other Net Income (Loss) Chart

Godavari Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Net Income (Loss)

Get a 7-Day Free Trial

Godavari Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Godavari Drugs Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Godavari Drugs Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Godavari Drugs (BOM:530317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003

Website

https://www.godavaridrugs.com

Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines